Addiction to topically used cyclopentolate hydrochloride: A case report
dc.contributor.buuauthor | Akkaya, Cengiz | |
dc.contributor.buuauthor | Zorlu Kocagoz, Sevilay | |
dc.contributor.buuauthor | Sarandöl, Aslı | |
dc.contributor.buuauthor | Eker, Salih Saygın | |
dc.contributor.buuauthor | Kırlı, Selçuk | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | ||
dc.contributor.scopusid | 14061855100 | tr_TR |
dc.contributor.scopusid | 24492525800 | tr_TR |
dc.contributor.scopusid | 14020405100 | tr_TR |
dc.contributor.scopusid | 14019347700 | tr_TR |
dc.contributor.scopusid | 14019745700 | tr_TR |
dc.date.accessioned | 2024-03-20T11:59:17Z | |
dc.date.available | 2024-03-20T11:59:17Z | |
dc.date.issued | 2008-10-01 | |
dc.description.abstract | ||
dc.identifier.citation | Akkaya, C. vd. (2008). "Addiction to topically used cyclopentolate hydrochloride: A case report". Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(7), 1752-1753 | en_US |
dc.identifier.endpage | 1753 | tr_TR |
dc.identifier.issn | 0278-5846 | |
dc.identifier.issn | 1878-4216 | |
dc.identifier.issue | 7 | tr_TR |
dc.identifier.pubmed | 18674584 | tr_TR |
dc.identifier.scopus | 2-s2.0-51349152656 | tr_TR |
dc.identifier.startpage | 1752 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/j.pnpbp.2008.07.003 | en_US |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0278584608002017 | en_US |
dc.identifier.uri | https://hdl.handle.net/11452/40526 | en_US |
dc.identifier.volume | 32 | tr_TR |
dc.identifier.wos | 000259843500025 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Psychiatry | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Abuse | en_US |
dc.subject.emtree | Carbamazepine | en_US |
dc.subject.emtree | Cholinergic receptor blocking agent | en_US |
dc.subject.emtree | Cyclopentolate | en_US |
dc.subject.emtree | Dexamethasone | en_US |
dc.subject.emtree | Escitalopram | en_US |
dc.subject.emtree | Fluoxetine | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Pimozide | en_US |
dc.subject.emtree | Risperidone | en_US |
dc.subject.emtree | Sertraline | en_US |
dc.subject.emtree | Addiction | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Alcohol abuse | en_US |
dc.subject.emtree | Behcet disease | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Depression | en_US |
dc.subject.emtree | Drug dose escalation | en_US |
dc.subject.emtree | Drug substitution | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Letter | en_US |
dc.subject.emtree | Major depression | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Patient compliance | en_US |
dc.subject.emtree | Uveitis | en_US |
dc.subject.emtree | Visual impairment | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Cyclopentolate | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Muscarinic antagonists | en_US |
dc.subject.mesh | Substance-related disorders | en_US |
dc.subject.other | Clinical neurology | en_US |
dc.subject.scopus | Case Report; Tropicamide; Orphenadrine | en_US |
dc.subject.wos | Clinical Neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & Pharmacy | en_US |
dc.subject.wos | Psychiatry | en_US |
dc.title | Addiction to topically used cyclopentolate hydrochloride: A case report | en_US |
dc.type | Letter | en_US |
dc.wos.quartile | Q2 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: